30.06.2016 | Biopsie | Onlineartikel
“The importance of first-line and second-line targeted agents is obvious”
Nir Peled MD, PhD, FCCP, Head of the Thoracic Cancer Unit, Thoracic Cancer Service, Davidoff Cancer Center, Petah Tikva, Israel